SENNA-S- senna and docusate sodium tablets, 8.6 mg and 50 mg tablet, coated 
HealthLife of USA LLC

----------

Senna-S - Senna and Docusate Sodium Tablets, 8.6 mg & 50 mg

Drug Facts

Active ingredients Purpose (in each tablet)          Purpose

Docusate sodium 50 mg.......................................Stool softner

Sennosides 8.6 mg................................................Laxative

Uses

Warnings

Do not use

  • if you are now taking mineral oil, unless directed by a doctor
  • laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that lasts over 2 weeks

Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

take preferably at bedtime or as directed by a doctor

Other information

Inactive ingredients

croscarmellose sodium, colloidal silicon dioxide, dicalcium phosphate, D&C Yellow # 10, FD&C Yellow # 6, hypromellose, microcrystalline cellulose, magnesium stearate, maltodextrin, polyethylene glycol, stearic acid, titanium dioxide

Questions or comments?

Call toll free 1-844-832-1138 Monday through Friday 9AM – 5PM EST or www.healthlifeofusa.com

PRINCIPAL DISPLAY PANEL

Compare to the Active Ingredients inSenokot-S®

*This product is not manufactured or distributed by Purdue Products L.P., owner of the registered trademark Senokot-S®.

Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg

Principal Display Panel

SENNA-S 
senna and docusate sodium tablets, 8.6 mg and 50 mg tablet, coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69517-131
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: O7TSZ97GEP)  
D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
POLYETHYLENE GLYCOL 1000 (UNII: U076Q6Q621)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
ColororangeScoreno score
ShapeROUNDSize10mm
FlavorImprint Code S35
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69517-131-2525 in 1 BOX04/08/2016
12 in 1 POUCH; Type 0: Not a Combination Product
2NDC:69517-131-5050 in 1 BOX04/08/2016
22 in 1 POUCH; Type 0: Not a Combination Product
3NDC:69517-131-022 in 1 POUCH04/08/2016
32 in 1 POUCH; Type 0: Not a Combination Product
4NDC:69517-131-101000 in 1 BOTTLE04/08/2016
4NDC:69517-131-05500 in 1 BOTTLE
4NDC:69517-131-2424 in 1 BOTTLE
41 in 1 CARTON; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph Drug505G(a)(3)03/07/2016
Labeler - HealthLife of USA LLC (079656178)
Establishment
NameAddressID/FEIBusiness Operations
Elysium Pharmaceutical Ltd.915664486manufacture(69517-131)

Revised: 10/2023
Document Id: 083396b6-6a49-ffc7-e063-6294a90ad8e2
Set id: 02a5299c-4b0d-47ac-9838-afd0b0fdd4a6
Version: 9
Effective Time: 20231021
 
HealthLife of USA LLC